CLX vs DEO Stock Comparison
DEO currently leads CLX in this stock comparison, with AIQ scores of 49 vs 46. The clearest difference is quality, while CLX has the stronger momentum profile.
What is the main difference between CLX and DEO?
DEO leads the current stock comparison as Diageo plc, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
The Clorox Company vs Diageo plc
DEO leads
DEO leads by 3 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 14 points over 30 sessions. Wall Street currently favors CLX on target upside.
Fragile: 3 of 6 evidence groups support DEO, its lead is narrowing, and its signal state is cleanly positive.
The Clorox Company
Diageo plc
The Algovestiq AIQ Score currently favors DEO over CLX, 49 versus 46 as of Nov 7, 2026. DEO's advantage is driven primarily by stronger quality and risk resilience, while CLX holds the stronger momentum profile. DEO also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors CLX. 3 of 6 covered evidence groups favor DEO today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. DEO lead: Weakening — the AIQ differential moved from 14 to 3 points over 30 sessions.
Compare The Clorox Company and Diageo plc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare CLX and DEO against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality19 vs 42DEO +23
- Momentum84 vs 73CLX +11
- Risk Resilience36 vs 45DEO +9
- Value45 vs 37CLX +8
3 of 6 evidence groups favor DEO. DEO’s edge is concentrated in quality and risk resilience; CLX keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-06, compared against the prior scored session 2026-11-05.
No factor moved materially.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 5 active signals are unchanged.
DEO's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — CLX and DEO both carry a full feed there.
The central trade-off
DEO (Diageo plc): the stronger current systematic profile, led by quality and risk resilience.
CLX (The Clorox Company): the counter-case, on momentum, value, valuation.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
DEODEO on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CLXCLX on combined revenue and EPS growth.
Value
CLXCLX on the peer-relative Value factor, by 8 points.
Momentum
CLXCLX on the Momentum factor, by 11 points.
Lower downside
DEODEO on Risk Resilience, by 9 points.
Analyst upside
CLXCLX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors DEO, analyst targets favor CLX. That disagreement is the most useful thing on this page.
| Measure | CLX | DEO | Note |
|---|---|---|---|
| Implied upside to target | -6.4% | -8.8% | CLX has more room |
| Target dispersion | +26.7% | +17.6% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 6 | 2 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
Dividend growth
| Dividend metric | CLX | DEO |
|---|---|---|
| 5Y dividend CAGR | 2.54% | 2.64% |
| 2020 regular DPS | $4.340 | $3.634 |
| 2025 regular DPS | $4.920 | $4.139 |
| Years increased | 5 | 3 |
| No cut in window | Yes | No (1) |
| Cohort rank | #314 | not ranked |
DEO grew its split-adjusted regular dividend faster over 2020–2025 — 2.64% a year against CLX's 2.54%. CLX never reduced its regular dividend in the window; DEO did in 1 year.
Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.
Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor DEO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 46 vs 49 |
| Fundamentals | DEOon balance | revenue growth 16.6% vs -11.8%; EPS growth -13% vs -112.4%; TTM ROE -18.9% vs 15.5%; gross margin 42.3% vs 59.5%; operating margin 24.7% vs 28.4% — DEO takes 3 of 5 decided legs, not all of them |
| Valuation | CLX | Value 45 vs 37 |
| Technicals | DEO | Price vs 50-day 14% vs 10.8%; vs 200-day 0.5% vs 15.8% |
| Risk Resilience | DEO | Risk Resilience 36 vs 45 |
| Analyst expectations | CLX | Target upside -6.4% vs -8.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CLX and DEO and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DEO.
How the comparison changed
120 daily snapshots · Jul 8 – Nov 6DEO lead: Weakening — the AIQ differential moved from 14 to 3 points over 30 sessions.
- Today
- DEO +3
- 46 vs 49
- 7 sessions ago
- DEO +11
- 38 vs 49
- 30 sessions ago
- DEO +14
- 38 vs 52
- 90 sessions ago
- DEO +14
- 30 vs 44
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 3 bearish, conflicted
Only CLX
- Death Cross Active — bearish, trend, long horizon (13.34%)
- BB Upper Band Breach — bearish, volatility, short horizon
- RSI Overbought — bearish, momentum, short horizon
5 bullish / 0 bearish
Only DEO
- Golden Cross Active — bullish, trend, long horizon (4.70%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: Keltner Channel Breakout, MACD Bullish Crossover.
CLX is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.26%, AIQ 0 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.49%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CLX closes the Quality gap — currently 23 points behind, the largest single contributor to DEO's edge.
- 2CLX's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3DEO's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4The narrowing continues — the lead has already given back 11 points over 30 sessions, and a further 3-point move would eliminate DEO's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
DEO leads on balance| Metric | CLX | DEO |
|---|---|---|
| Revenue growth (YoY) | 16.6% | -11.8% |
| EPS growth (YoY) | -13% | -112.4% |
| Gross margin | 42.3% | 59.5% |
| Operating margin | 24.7% | 28.4% |
| Return on equity (TTM) | -18.9% | 15.5% |
| Debt to equity | 61.33 | 2.03 |
Performance
DEO leads 4 of 6 windows| Metric | CLX | DEO |
|---|---|---|
| 1 week (5 sessions) | 12.1% | 6.8% |
| 1 month (20 sessions) | 17.3% | 15% |
| 3 months (63 sessions) | -7.2% | 2.7% |
| 6 months (126 sessions) | 8.5% | 18.3% |
| Year to date | -0.9% | 15.6% |
| 1 year (252 sessions) | -8.8% | 6.2% |
Technicals
DEO has the stronger structure| Metric | CLX | DEO |
|---|---|---|
| RSI (14) | 77 | 61.9 |
| ADX (14) | 29.2 | 24.4 |
| Price vs 50-day | 14% | 10.8% |
| Price vs 200-day | 0.5% | 15.8% |
| Volatility (1M, annualized) | 35.5% | 35.7% |
Risk
DEO is the more resilient| Metric | CLX | DEO |
|---|---|---|
| Beta | 0.32 | 0.11 |
| Sharpe ratio | -0.14 | 0.45 |
| Sortino ratio | -0.21 | 0.62 |
| Max drawdown | -36.8% | -29.1% |
| Current drawdown | -21.4% | -2.3% |
| Annualized volatility | 32.7% | 33.5% |
| Value at risk (95%) | -3.1% | -2.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CLX or DEO?
On the Algovestiq AIQ Score, DEO is the stronger of the two as of Nov 7, 2026, scoring 49 against CLX's 46. The edge comes from quality and risk resilience. CLX is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CLX or DEO the better buy right now?
DEO carries the stronger systematic profile as of Nov 7, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.
Why does the AIQ Score favor DEO over CLX?
The composite weights Quality, Value, Momentum and Risk Resilience. DEO leads Quality by 23 points; CLX leads Momentum by 11 points; DEO leads Risk Resilience by 9 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CLX or DEO?
Analyst price targets imply -6.4% upside for CLX and -8.8% for DEO, so the Street currently favors CLX. That points the opposite way to the AIQ Score, which favors DEO. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CLX or DEO?
CLX is the better-valued of the two on the peer-relative Value factor. CLX on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CLX or DEO?
CLX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CLX or DEO?
CLX on the Momentum factor, by 11 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CLX or DEO?
DEO is the more resilient of the two, so the other name carries the higher downside risk. DEO on Risk Resilience, by 9 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CLX more profitable than DEO?
DEO leads on the comparable margin measures — gross margin 42.3% vs 59.5%; operating margin 24.7% vs 28.4%; ttm roe -18.9% vs 15.5%.
Is DEO's lead over CLX getting stronger or weaker?
DEO lead: Weakening — the AIQ differential moved from 14 to 3 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-07-08 and 2026-11-06. The lead has not changed hands in that window.
What would change the CLX vs DEO verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CLX closes the Quality gap — currently 23 points behind, the largest single contributor to DEO's edge; CLX's Death Cross Active resolves — a bearish trend rule currently active against it; DEO's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; the narrowing continues — the lead has already given back 11 points over 30 sessions, and a further 3-point move would eliminate DEO's advantage entirely.
What do the current signals say about CLX and DEO?
CLX: 2 bullish / 3 bearish, conflicted. DEO: 5 bullish / 0 bearish. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CLX is Death Cross Active (bearish, long horizon). On DEO it is Golden Cross Active (bullish, long horizon).
Compare CLX and DEO with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.